Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 107 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning trading, 87 companies set new 52-week lows.
SVB Leerink Maintains Outperform on Werewolf Therapeutics, Lowers Price Target to $28
SVB Leerink analyst Daina Graybosch maintains Werewolf Therapeutics (NASDAQ:HOWL) with a Outperform and lowers the price target from $29 to $28.
Werewolf Therapeutics Q3 EPS $(0.51) Up From $(6.61) YoY
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.51) per share. This is a 92.28 percent increase over losses of $(6.61) per share from the same period last year.
B of A Securities Initiates Coverage On Werewolf Therapeutics with Buy Rating, Announces Price Target of $26
B of A Securities initiates coverage on Werewolf Therapeutics (NASDAQ:HOWL) with a Buy rating and announces Price Target of $26.
Werewolf Therapeutics Inks Solid Tumor Trial Collaboration With Merck
Werewolf Therapeutics Inc (NASDAQ: HOWL) has entered into a
Werewolf Therapeutics Announces Clinical Trial Collaboration With Merck On Its WTX-124 INDUKINE Program
Werewolf Therapeutics, Inc. (NASDAQ:HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment